Effects of Personalized Aerobic-Exercise and Resistance-Training Prescriptions on College Students with Anxiety During the COVID-19

The COVID-19 pandemic has seriously increased anxiety prevalence among the public, including Chinese college students. However, many exercises cannot be performed as usual under the stay-at-home order. The purpose of this study was to evaluate and compare the effect of personalized individual aerobic-exercise and resistance-training prescriptions on anxiety in college students during the COVID-19. This was a 12-week three-arm randomized control trial using the intention-to-treat principle. Sixty-six college students with anxiety were recruited and randomized into aerobic-exercise (AE), resistance-training (RT), and health-education group (HE). AE and RT groups also received health education. Measures on anxiety and physical activity included Zung Self-Rating Anxiety Scale (SAS), Chinese College Students Mental Health Scale - Anxiety Subscale (CCSMHS-AS) and International Physical Activity Questionnaire-Short Form (IPAQ-SF). All data were collected at the baseline, 4, 8, 12 weeks and 4-week post-intervention. All participants completed the intervention and measurements. The mean (SD) of SAS, CCSMHS-AS score and physical activity was 56.36 (5.63), 19.27 (4.56), 1306.57 (1421.19) (met-min/week). After the intervention, 78.79% of anxiety participants improved from anxiety to “normal”. Participants in all groups showed a statistically and clinically significant improvement after 12-week intervention (p \u3c 0.001). Moreover, such improvement was well-maintained in RT and HE group as there were no significant differences in SAS and CCSMHS-AS at 4-week post-intervention compared to 12 weeks (p \u3e 0.05). However, the SAS score of participants in AE group showed a significant increase during the 4 weeks after intervention (p \u3c 0.05). No significant differences were observed in the effect of AE and RT on anxiety at each time-point (p \u3e 0.05). PA of participants in AE and RT group represented a significant improvement at 4-week post-intervention compared to baseline (p \u3c 0.01). Personalized individual aerobic-exercise and resistance-training combined with health-education resulted in a similar effect on reducing anxiety and improving physical activity, and the effect was better than health education alone. Furthermore, the effect of resistance-training and health-education on reducing anxiety was more stable than that of aerobic-exercise. We recommended 45- to 60-minute home-based individual exercise (including 30- to 40-minute main exercise) with progressive moderate-to-high intensity, 3 times/week for at least 12 weeks for those students with anxiety during the COVID-19 pandemic

Cyanogel-Based Preparation of Amorphous NiFe Nanoaggregates with Enhanced Activity and Stability for OER

The development of cost-efficient electrocatalysts for oxygen evolution reaction (OER) with high efficiency is crucial to widespread applications of water splitting for hydrogen production. In this work, porous three-dimensional (3D) amorphous NiFe nanoaggregates composed of interconnected nanograins were synthesized by a cyanogel-based wet chemical reduction method using the NiCl2/Na4Fe(CN)6 cyanogel as the precursor and NaBH4 as the reducing agent. The influence of the incorporated Fe amount was carefully studied by slightly changing the feeding molar ratios of the Ni/Fe atoms in the precursors. The intrinsic 3D backbone structure of the cyanogel resulted in crystal nuclei tending to generate along with the backbones, which is key to the formation of NiFe nanoaggregates with a porous 3D interconnected structure. The synthesized NiFe nanoaggregates with a 3D interconnected structure and high porosity, as well as the incorporation of Fe, are in favor of high surface area, more active sites, and abundant oxygen vacancies, leading to superior activity and stability of OER in alkaline electrolytes with a low overpotential of 0.35 V at 10 mA cm−2, a high current density of 24.8 mA cm−2 at 1.65 V, a small Tafel slope of 76.9 mV dec−1, and attractive durability in 1 M KOH solution

Advances in the Anti-Tumor Activity of Biflavonoids in <i>Selaginella</i>

Despite the many strategies employed to slow the spread of cancer, the development of new anti-tumor drugs and the minimization of side effects have been major research hotspots in the anti-tumor field. Natural drugs are a huge treasure trove of drug development, and they have been widely used in the clinic as anti-tumor drugs. Selaginella species in the family Selaginellaceae are widely distributed worldwide, and they have been well-documented in clinical practice for the prevention and treatment of cancer. Biflavonoids are the main active ingredients in Selaginella, and they have good biological and anti-tumor activities, which warrant extensive research. The promise of biflavonoids from Selaginella (SFB) in the field of cancer therapy is being realized thanks to new research that offers insights into the multi-targeting therapeutic mechanisms and key signaling pathways. The pharmacological effects of SFB against various cancers in vitro and in vivo are reviewed in this review. In addition, the types and characteristics of biflavonoid structures are described in detail; we also provide a brief summary of the efforts to develop drug delivery systems or combinations to enhance the bioavailability of SFB monomers. In conclusion, SFB species have great potential to be developed as adjuvant or even primary therapeutic agents for cancer, with promising applications

Evaluation of recombinant protein superoxide dismutase of Haemophilus parasuis strain SH0165 as vaccine candidate in a mouse model

Haemophilus parasuis, can cause a severe membrane inflammation disorder. It has been documented that superoxide dismutase is a potential target to treat systemic inflammatory diseases. Therefore, we constructed an experimental H. parasuis subunit vaccine SOD and determined the protective efficacy of SOD using a lethal dose challenge against H. parasuis serovar 4 strain MD0322 and serovar 5 strain SH0165 in a mouse model. The results demonstrated that SOD could induce a strong humoral immune response in mice and provide significant immunoprotection efficacy against a lethal dose of H. parasuis serovar 4 strain MD0322 or serovar 5 strain SH0165 challenge. IgG subtype analysis indicated SOD protein could trigger a bias toward a Th1-type immune response and induce the proliferation of splenocytes and secretion of IL-2 and IFN-Îł of splenocytes. In addition, serum in mice from SOD immunized group could inhibit the growth of strain MD0322 and strain SH0165 in the whole-blood killing bacteria assay. It was the first time reported that immunization of mice with SOD protein could provide protective effect against a lethal dose of H. parasuis serovar 4 and serovar 5 challenge in mice, which may provide a novel approach against heterogenous serovar infection of H. parasuis in future.The accepted manuscript in pdf format is listed with the files at the bottom of this page. The presentation of the authors' names and (or) special characters in the title of the manuscript may differ slightly between what is listed on this page and what is listed in the pdf file of the accepted manuscript; that in the pdf file of the accepted manuscript is what was submitted by the author

Total biflavonoids extraction from Selaginella chaetoloma utilizing ultrasound-assisted deep eutectic solvent: Optimization of conditions, extraction mechanism, and biological activity in vitro

In this study, the deep eutectic solvent based ultrasound-assisted extraction (DES-UAE) was investigated for the efficient and environmentally friendly extraction of Selaginella chaetoloma total biflavonoids (SCTB). As an extractant for optimization, tetrapropylaminium bromide-1,4-butanediol (Tpr-But) was employed for the first time. 36 DESs were created, with Tpr-But producing the most effective results. Based on response surface methodology (RSM), the greatest extraction rate of SCTB was determined to be 21.68 ± 0.78 mg/g, the molar ratio of HBD to HBA was 3.70:1, the extraction temperature was 57 °C, and the water content of DES was 22 %. In accordance with Fick's second rule, a kinetic model for the extraction of SCTB by DES-UAE has been derived. With correlation coefficients 0.91, the kinetic model of the extraction process was significantly correlated with the general and exponential equations of kinetics, and some important kinetic parameters such as rate constants, energy of activation and raffinate rate were determined. In addition, molecular dynamics simulations were used to study the extraction mechanisms generated by different solvents. Comparing the effect of several extraction methods on S.chaetoloma using ultrasound-assisted extraction and conventional methods, together with SEM examination, revealed that DES-UAE not only saved time but also enhanced SCTB extraction rate by 1.5–3 folds. SCTB demonstrated superior antioxidant activity in three studies in vitro. Furthermore, the extract could suppress the growth of A549, HCT-116, HepG2, and HT-29 cancer cells. Alpha-Glucosidase (AG) inhibition experiment and molecular docking studies suggested that SCTB exhibited strong inhibitory activity against AG and potential hypoglycemic effects. The results of this study indicated that a Tpr-But-based UAE method was suitable for the efficient and environmentally friendly extraction of SCTB, and also shed light on the mechanisms responsible for the increased extraction efficiency, which could aid in the application of S.chaetoloma and provide insight into the extraction mechanism of DES

The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes

Abstract Diabetes is one of the most common phenotypes of Wolfram syndrome owing to the presence of the variants of the WFS1 gene and is often misdiagnosed as other types of diabetes. We aimed to explore the prevalence of WFS1-related diabetes (WFS1-DM) and its clinical characteristics in a Chinese population with early-onset type 2 diabetes (EOD). We sequenced all exons of the WFS1 gene in 690 patients with EOD (age at diagnosis ≤ 40 years) for rare variants. Pathogenicity was defined according to the standards and guidelines of the American College of Medical Genetics and Genomics. We identified 33 rare variants predicted to be deleterious in 39 patients. The fasting [1.57(1.06–2.22) ng/ml] and postprandial C-peptide levels [2.8(1.75–4.46) ng/ml] of the patients with such WFS1 variations were lower than those of the patients without WFS1 variation [2.09(1.43–3.05) and 4.29(2.76–6.07) respectively, ng/ml]. Six (0.9%) patients carried pathogenic or likely pathogenic variants; they met the diagnostic criteria for WFS1-DM according to the latest guidelines, but typical phenotypes of Wolfram syndrome were seldom observed. They were diagnosed at an earlier age and usually presented with an absence of obesity, impaired beta cell function, and the need for insulin treatment. WFS1-DM is usually mistakenly diagnosed as type 2 diabetes, and genetic testing is helpful for individualized treatment

New clinical screening strategy to distinguish HNF1A variant-induced diabetes from young early-onset type 2 diabetes in a Chinese population

ObjectiveMaturity-onset diabetes of the young caused by hepatocyte nuclear factor-1 alpha (HNF1A) variants (HNF1A-MODY) is a common form of monogenetic diabetes. Although patients with HNF1A-MODY might specifically benefit from sulfonylurea treatment, available methods for screening this specific type of diabetes are not cost-effective. This study was designed to establish an optimized clinical strategy based on multiple biomarkers to distinguish patients with HNF1A-MODY from clinically diagnosed early-onset type 2 diabetes (EOD) for genetic testing in a Chinese population.Research design and methodsA case–control study including 125 non-related young patients with EOD and 15 probands with HNF1A-MODY (cohort 1) was conducted to evaluate reported biomarkers for HNF1A-MODY. A cut-off for the fasting insulin (Fins) level, the 97.5 percentile of 150 healthy subjects with normal components of metabolic syndrome (cohort 2), was used to filter out individuals with obvious insulin resistance (Fins &lt;102 pmol/L). An optimized clinical screening strategy (HNF1A-CSS) was established, and its effectiveness was assessed in another group of 410 young patients with EOD (cohort 3).ResultsIn cohort 1, body mass index (BMI), serum high-density lipoprotein cholesterol (HDL-c) and high-sensitivity C reactive protein (hs-CRP) levels were confirmed to be useful for the differential diagnosis of HNF1A-MODY. In cohort 3, eight probands with HNF1A-MODY were identified. In cohort 3 and young relatives with HNF1A-MODY, meeting three of four criteria (BMI &lt;28 kg/m2, hs-CRP &lt;0.75 mg/L, Fins &lt;102 pmol/L and HDL-c &gt;1.12 mmol/L), the sensitivity and specificity of HNF1A-CSS were 100% and 69.3%, respectively. In the pooled analysis of all young patients, HNF1A-CSS displayed 90.5% sensitivity and 73.6% specificity for identifying patients with HNF1A-MODY among those with clinically diagnosed EOD.ConclusionOur HNF1A-CSS is useful for distinguishing patients with HNF1A-MODY from patients with EOD in a young Chinese population